President Barack Obama should urge House and Senate negotiators to end the ban against federal funding for syringe exchange in order to curb HIV and viral hepatitis infections in the US. This was his position as a candidate for the White House and the position he reiterated upon assuming office earlier this year.
Without White House intervention, House and Senate appropriators are likely to negotiate a final bill that fails to embrace a provision championed by House Appropriations Chairman David Obey (D-WI) to end the decades-old funding ban.
Moreover, the District of Columbia, where HIV prevalence rates rival those in Sub-Saharan Africa, could be hamstrung in its efforts to combat the nation's worst HIV epidemic. Just last year, Washington, DC secured the legal authority in legislation signed by President George W. Bush to spend municipal taxpayer dollars on syringe-exchange services as part of a comprehensive response to the epidemic. It would be an embarrassment for President Obama if the District of Columbia were to again be restricted by law from responding to the needs of its residents.
The Obama Administration is taking a bold step by leading efforts to develop the nation's first-ever National HIV/AIDS Strategy, but progress against syringe-related HIV infections must not wait for this planning process to produce yet another government recommendation that public policy follow the science. Put plainly, syringe exchange effectively and cheaply prevents cases of HIV and viral hepatitis without increasing drug use or crime. The lack of adequate access to sterile syringes and addiction treatment services remains an egregious gap in our public response to preventable diseases. Foregoing effective interventions has already generated significant medical costs and caused immeasurable human suffering.
Congressional negotiators are likely to listen to the President if he urges them to end the ban and other restrictive provisions against syringe-exchange access. The question now is whether Mr. Obama intends to keep his promise.
Sincerely,
David Ernesto Munar, Vice President
AIDS Foundation of Chicago
Katie Caldwell, President/CEO
Legacy Community Health Services
Houston, TX
Mark Cloutier
CEO, San Francisco AIDS Foundation
President, Pangaea Global AIDS Foundation
San Francisco, CA
Kandy Ferree, President/CEO
National AIDS Fund
Washington, DC
Rebecca Haag, CEO/President
AIDS Action Committee of Massachusetts
Boston, MA
Marjorie Hill, PhD, President/CEO
Gay Men's Health Crisis
New York, NY
David Holtgrave, PhD
Baltimore, MD
Mark Ishaug, President/CEO
AIDS Foundation of Chicago
Chicago, IL
Paul Kawata, Executive Director
National Minority AIDS Council
Washington, DC
Dr. Celia Maxwell
Howard University Hospital
Washington, DC
Craig E. Thompson, Executive Director
AIDS Project Los Angeles
Los Angeles, CA
Phill Wilson, Executive Director
Black AIDS Institute
Los Angeles, CA
The twelve authors are leading AIDS advocate working with local, state, and national partners to advance the fight against HIV/AIDS in the U.S.
